HCSGD entry for MAOA
1. General information
| Official gene symbol | MAOA |
|---|---|
| Entrez ID | 4128 |
| Gene full name | monoamine oxidase A |
| Other gene symbols | MAO-A |
| Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
|---|---|---|---|
| GO:0005741 | Mitochondrial outer membrane | TAS | cellular_component |
| GO:0006576 | Cellular biogenic amine metabolic process | TAS | biological_process |
| GO:0006805 | Xenobiotic metabolic process | TAS | biological_process |
| GO:0007268 | Synaptic transmission | TAS | biological_process |
| GO:0007269 | Neurotransmitter secretion | TAS | biological_process |
| GO:0007610 | Behavior | TAS | biological_process |
| GO:0008131 | Primary amine oxidase activity | TAS | molecular_function |
| GO:0016021 | Integral component of membrane | IEA | cellular_component |
| GO:0042135 | Neurotransmitter catabolic process | IEA | biological_process |
| GO:0042136 | Neurotransmitter biosynthetic process | TAS | biological_process |
| GO:0042420 | Dopamine catabolic process | IEA | biological_process |
| GO:0044281 | Small molecule metabolic process | TAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
| p-value up | p-value down | FDR up | FDR down |
|---|---|---|---|
| 0.2793665476 | 0.0485297899 | 0.9762610964 | 0.4121711935 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
| Data source | Up or down | Log fold change |
|---|---|---|
| GSE11954 | Down | -0.0110290399 |
| GSE13712_SHEAR | Down | -0.8856013246 |
| GSE13712_STATIC | Down | -0.7213529531 |
| GSE19018 | Down | -0.2604970729 |
| GSE19899_A1 | Up | 0.0291876597 |
| GSE19899_A2 | Up | 0.5277538372 |
| PubMed_21979375_A1 | Up | 2.0533331269 |
| PubMed_21979375_A2 | Up | 0.4036714015 |
| GSE35957 | Up | 0.3559264738 |
| GSE36640 | Down | -0.0643402260 |
| GSE54402 | Down | -0.2624056609 |
| GSE9593 | Down | -0.1716378107 |
| GSE43922 | Down | -0.0666075248 |
| GSE24585 | Down | -1.2601874207 |
| GSE37065 | Up | 0.0389213178 |
| GSE28863_A1 | Down | -0.2768731386 |
| GSE28863_A2 | Up | 0.2051467728 |
| GSE28863_A3 | Up | 0.3074046289 |
| GSE28863_A4 | Up | 0.0123197627 |
| GSE48662 | Up | 0.0001458901 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
|---|---|---|
| Phentermine | DB00191 | APRD00093 |
| Tranylcypromine | DB00752 | APRD00645 |
| Phenelzine | DB00780 | APRD00099 |
| Minaprine | DB00805 | APRD00735 |
| Zonisamide | DB00909 | APRD00004 |
| Selegiline | DB01037 | APRD00525 |
| Isocarboxazid | DB01247 | APRD00701 |
| Ephedra | DB01363 | - |
| MMDA | DB01442 | - |
| 4-Methoxyamphetamine | DB01472 | EXPT03303 |
| Pargyline | DB01626 | - |
| N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine | DB04017 | EXPT02182 |
| Zimelidine | DB04832 | - |
| Posizolid | DB04850 | - |
| CX157 | DB05205 | - |
| DECYL(DIMETHYL)PHOSPHINE OXIDE | DB07641 | - |
| 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE | DB07919 | - |
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
|---|---|---|---|---|---|
| hsa-miR-22-3p | MIMAT0000077 | MIRT005902 | Luciferase reporter assay//Microarray | Functional MTI | 21168126 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 2 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
|---|---|
| 9564604 | Relationship between monoamine oxidase (MAO) A specific activity and proportion of human skin fibroblasts which express the enzyme in culture |
| 9564604 | Total deficiency of monoamine oxidase A (MAO-A) in affected males of a single, human kindred appears to be associated with mild mental retardation and significant behavioral anomalies |
| 9564604 | Though total MAO-A deficiency appears to be rare, the extent and significance of individual variation in monoamine oxidase A activity in human populations is unclear |
| 9564604 | Since MAO-A activity is undetectable in blood cells, most systematic surveys of individual variation MAO-A activity have compared enzyme activity in human fibroblasts cultured from skin biopsies |
| 9564604 | Surprisingly, MAO-A activity in skin fibroblast cultures from unrelated donors ranges over 100-fold |
| 9564604 | It has been suggested that this extreme variation in fibroblast MAO-A activity between donors reflects individual, genetic variation in the regulation of MAO-A in fibroblasts |
| 9564604 | I have found from studies with immunofluorescence microscopy and flow cytometry that the proportion of MAO-A+ cells in fibroblast cultures is (a) highly variable between cultures, (b) a reproducible characteristic of each culture and (c) the primary factor responsible for variation in MAO-A specific activity in whole cell, skin fibroblast homogenates |
| 9564604 | It has been shown previously that MAO-A activity of a skin fibroblast culture is relatively constant with continued passage prior to cellular senescence |
| 9564604 | Therefore, these new data raise the possibility that MAO-A expression is confined to a functionally distinct subset of human skin fibroblasts |
| 3731213 | Two forms of monoamine oxidase (MAO A and MAO B) exist which, although similar in a number of properties, can be distinguished on the basis of their substrate specificity, inhibitor sensitivity, kinetic parameters, and protein structure |
| 3731213 | These properties were used to study the molecular mechanism(s) by which glucocorticoid hormones and "aging," known to alter MAO activity in vivo, regulated the expression of MAO A and MAO B in cultured human skin fibroblasts |
| 3731213 | The 6- to 14-fold increases in total activity were paralleled by similar increases in the activity and amount of active MAO A but less than 2- to 3-fold increases in the activity and amount of MAO B |
| 3731213 | In summary, we have shown that glucocorticoids and cellular aging selectively affect the amount of MAO A at the level of active enzyme synthesis or degradation |
| 3731213 | Further, our finding that the expression of the two forms of MAO in human fibroblasts can be independently regulated supports the growing evidence that MAO A and MAO B are separate molecular entities |
Entries Per Page
Displaying Page of

